Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Reprogrammed Skin Cells Could Lead to Alzheimer’s Cure

October 15, 2014 By University of Wollongong

Neuroscientists from UOW are reprogramming skin cells in order to discover new treatments and ultimately a cure for a range of devastating brain diseases such as Alzheimer’s, Schizophrenia and Motor Neurone Disease.

Dr Lezanne Ooi, from the Illawarra Health and Medical Research Institute based at UOW, is at the forefront of an exciting new branch of neuroscience that converts donated human cells back to their original pluripotent stem cell state so that they can be used in disease modelling and drug discovery.

“In my lab, we are trying to understand the differences in cells from patients who suffer from diseases like Alzheimer’s compared to people who don’t,” Dr Ooi said.

“One of the ways that we started to tackle this problem is by taking donated skin cells from patients and reprograming those cells to a stem cell like state. We then use those cells to generate brain cells (and other cells that represent the disease) in a dish. From there, we try to use those cells to identify new treatments or to understand the reasons why those cells are different and die in diseases like Alzheimer’s.”

This new method of reprogramming cells was originally invented in 2006 and won the Nobel Prize in the category of ‘Physiology or Medicine’ in 2012.

Dr Ooi and her team have already started to look at cells from Alzheimer’s patients and compare them to patients who don’t have the disease.

“We’ve identified a couple of compounds that are able to protect those cells from getting the disease in a dish. We have a little way to go, but we are starting to understand the mechanism behind why those compounds are protective,” she said.

Dr Ooi said the field is moving incredibly quickly because scientists around the world have realised that almost any disease can be modelled using this method.

She said the technology is also a step closer to personalised medicines, as the donated cultured cells provide an avatar for the real patient, where in the future doctors can test how the patient might react to a particular drug.

It could also be used to replace cells that are lost as a disease progresses. For example, in Motor Neurone Disease, motor neurones degenerate and die, so patients lose their motor control – the ability to walk, talk, swallow and eventually, breathe.

“If we can generate motor neurones in a dish from a patient’s cells, then we might get to a point where we can transplant those motor neurones back into the patient and improve their chances of living and improve their quality of life as well,” she said.

UK-born Dr Ooi said she has always been fascinated with the brain – an area of the body that is often described as the ‘last frontier’ of medicine.

“There is still so much that we don’t know about how the brain works and what happens when it goes awry,” she said.

“On a personal level, my gran has Alzheimer’s and as a scientist I need to understand the process that she is going through on a biological level, to understand why some people suffer from this disease and to contribute to knowledge that may one day aid the development of better treatments.”

Related Articles Read More >

A photo of the Paradromics Connexus brain-computer interface on a fingertip.
How Paradromics designed its Connexus brain-computer interface system
An illustration of HITMAN operating in glioblastoma cells.
MIT researchers develop injectable nanodevices that remotely kill brain tumor cells
An illustration of CSF flow through the brain.
MIT researchers find pink noise can encourage CSF flow during sleep
A photo of Kitea Health's Kitea Sensor with fingers for scale.
Intracranial sensor maker says automated testing slashed firmware development time
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe